Non-small cell lung cancer: Which Medications Cause It? (3,494 Reports Across 136 Drugs)
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Non-small cell lung cancer has been reported as an adverse event with 136 different drugs in the FDA's FAERS database, with 3,494 total reports. 1,327 of these reports resulted in death.The drugs most commonly associated with Non-small cell lung cancer are SOTORASIB, CARBOPLATIN, and BRIGATINIB.
3,494
Total Reports
136
Drugs Involved
1,327
Deaths
840
Hospitalizations
64.3 yrs
Average Patient Age
46.0% / 54.0%
Female / Male
Which Drugs Cause Non-small cell lung cancer Most Often?
| Drug | Reports | % of Drug Reports | Deaths | Hosp. | Life-Threat. |
|---|---|---|---|---|---|
| SOTORASIB | 483 | 16.5% | 131 | 55 | 11 |
| CARBOPLATIN | 431 | 0.5% | 154 | 109 | 19 |
| BRIGATINIB | 370 | 11.3% | 69 | 63 | 6 |
| NIVOLUMAB | 366 | 0.4% | 132 | 127 | 18 |
| PACLITAXEL | 275 | 0.4% | 107 | 80 | 11 |
| IPILIMUMAB | 273 | 0.8% | 106 | 97 | 12 |
| PEMETREXED | 234 | 1.0% | 57 | 47 | 7 |
| CERITINIB | 183 | 6.6% | 83 | 53 | 2 |
| CRIZOTINIB | 178 | 1.8% | 97 | 60 | 29 |
| AMG-510 | 134 | 36.7% | 56 | 22 | 6 |
| BEVACIZUMAB | 118 | 0.2% | 56 | 16 | 5 |
| CAPMATINIB | 96 | 4.2% | 37 | 21 | 6 |
| MOBOCERTINIB | 96 | 13.4% | 43 | 21 | 1 |
| ATEZOLIZUMAB | 91 | 0.3% | 60 | 18 | 5 |
| DOCETAXEL | 85 | 0.1% | 40 | 15 | 2 |
| ERLOTINIB | 82 | 0.4% | 53 | 25 | 2 |
| RITUXIMAB | 81 | 0.1% | 31 | 9 | 0 |
| DABRAFENIB | 79 | 0.4% | 31 | 29 | 2 |
| OSIMERTINIB | 79 | 0.3% | 27 | 9 | 3 |
| METHOTREXATE | 77 | 0.0% | 14 | 22 | 15 |